Anus leiomyosarcoma

Summary

Anus leiomyosarcoma (MONDO:0003358) is a disease. A subtype of anus sarcoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	anus leiomyosarcoma
Mondo ID	MONDO:0003358
DOID	DOID:5267
NCIT	C5599
UMLS	C1332267
MedGen	231370
GARD	0023473
Anatomy (UBERON)	UBERON:0001245
Is cancer (heuristic)	no

Also known as: anal leiomyosarcoma · anus leiomyosarcoma · leiomyosarcoma of anus · leiomyosarcoma of the anus

Disease family

Classification path: human disease › disease by body system or component › digestive system disorder › intestinal disorder › large intestine disorder › rectal disorder › rectal neoplasm › anus neoplasm › anus cancer › anus sarcoma › anus leiomyosarcoma

Related subtypes (1): anus rhabdomyosarcoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.